Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Pyrimidine SCHEMBL16987122 | 0.97 | ALDH1A1 (0.68) | ALDH1A1FKBP5 | |
| Imidazole SCHEMBL27621126 | 0.88 | ALDH1A1 (0.81) | ALDH1A1FKBP5 | |
| Benzene SCHEMBL18279961 | 0.85 | ALDH1A1 (0.87) | ALDH1A1FKBP5 | |
| Benzene SCHEMBL29168770 | 0.85 | ALDH1A1 (0.87) | ALDH1A1FKBP5 | |
| Benzene SCHEMBL5088215 | 0.85 | ALDH1A1 (0.87) | ALDH1A1FKBP5 | |
| Imidazole SCHEMBL2635292 | 0.85 | — | — | |
| Imidazole SCHEMBL2684565 | 0.85 | ALDH1A1 (1.00) | ALDH1A1FKBP5 | |
| Imidazole SCHEMBL1331920 | 0.85 | — | — | |
| Imidazole SCHEMBL1331382 | 0.85 | — | — | |
| Imidazole SCHEMBL28744226 | 0.85 | ALDH1A1 (1.00) | ALDH1A1FKBP5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 196 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116217558-A | GLP-1 receptor agonist, preparation method and medical application thereof | 深圳信立泰药业股份有限公司 | 2023-06-06 | — | — | CN | claimed |
| CN-103304428-B | Aminated compounds, organic illuminating element and organic light emitting apparatus comprising aminated compounds | 三星显示有限公司 | 2018-10-19 | — | — | CN | claimed |
| CN-107001292-A | Organic photovoltaic component compound and organic photovoltaic component and display element | 三星SDI株式会社 | 2017-08-01 | — | — | CN | claimed |
| CN-105529400-A | ORGANIC LIGHT-EMITTING DEVICE | SAMSUNG DISPLAY CO LTD | 2016-04-27 | — | — | CN | claimed |
| CN-103247761-A | Organic light-emitting device having improved efficiency characteristics and organic light-emitting display apparatus including the same | SAMSUNG DISPLAY CO LTD | 2013-08-14 | — | — | CN | claimed |
| CN-102686600-A | Novel prodrugs of steroidal cyp17 inhibitors/antiandrogens | TOKAI PHARMACEUTICALS | 2012-09-19 | — | — | CN | claimed |
| EP-1004299-B1 | VACCINE PRECURSORS, VACCINES FOR TREATING TUMORS | KOYAMA SHOZO (JP) | 2009-11-04 | — | — | EP | claimed |
| US-7605183-B2 | Inhibitory or blocking agents of molecular generating and/or inducing functions | KOYAMA SHOZO | 2009-10-20 | — | — | US | claimed |
| US-20080200558-A1 | Inhibitory or blocking agents of molecular generating and/or/ inducing functions | KOYAMA SHOZO | 2008-08-21 | — | — | US | claimed |
| EP-0780122-B1 | DEPRESSANT OF FUNCTIONS DEVELOPED BY MOLECULE | KOYAMA SHOZO (JP) | 2006-11-22 | — | — | EP | claimed |
| EP-1414464-A2 | METHOD FOR TREATING GLAUCOMA V | Alteon, Inc. (US) | 2004-05-06 | — | — | EP | claimed |
| EP-1406611-A2 | METHOD FOR TREATING FIBROTIC DISEASES OR OTHER INDICATIONS | Alteon, Inc. (US) | 2004-04-14 | — | — | EP | claimed |
| WO-2002096318-A2 | METHOD FOR TREATING GLAUCOMA V | ALTEON, INC. (US) | 2002-12-05 | — | — | WO | claimed |
| WO-2002096363-A2 | METHOD FOR TREATING FIBROTIC DISEASES OR OTHER INDICATIONS | ALTEON, INC. (US) | 2002-12-05 | — | — | WO | claimed |
| US-20020165206-A1 | Inhibitory or blocking agents of molecular generating and/or inducing functions | KOYAMA SHOZO (JP) | 2002-11-07 | — | — | US | claimed |
| US-6346551-B1 | ANTIBACTERIAL, ANTIFUNGAL, ANTIVIRAL, BACTERICIDAL AND/OR STERILIZATION AGENTS, ANTICANCER DRUGS, BLOOD COAGULATION AND FIBRINOLYSIS INHIBITORS AND/OR BLOCKING AGENTS, INHIBITORY AND/OR BLOCKING AGENTS OF ANTIGEN-ANTIBODY REACTIONS | KOYAMA SHOZO (JP) | 2002-02-12 | — | — | US | claimed |
| US-20020009467-A1 | Antigenic substance inductor, vaccine precursor, vaccine, antibody, neutralizing antibody, antitoxin, idiotype antibody and/or anti-idiotype antibody which is induced by its idiotype antibody | KOYAMA SHOZO (JP) | 2002-01-24 | — | — | US | claimed |
| EP-1004299-A1 | ANTIGEN INDUCERS, VACCINE PRECURSORS, VACCINES, ANTIBODIES, NEUTRALIZING ANTIBODIES, ANTITOXINS, IDIOTYPIC ANTIBODIES, AND ANTI-IDIOTYPIC ANTIBODIES INDUCED BY THE IDIOTYPIC ANTIBODIES | Koyama, Shozo (JP) | 2000-05-31 | — | — | EP | claimed |
| CN-1162918-A | Depressant of functions developed by molecule | KOYAMA SHOZO (JP) | 1997-10-22 | — | — | CN | claimed |
| EP-0780122-A1 | DEPRESSANT OF FUNCTIONS DEVELOPED BY MOLECULE | Koyama, Shozo (JP) | 1997-06-25 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020165206-A1 | Inhibitory or blocking agents of molecular generating and/or inducing functions | CD69, TFPI, SERPINE1 | ALDH1A1 2177/4885FKBP5 3266/4885 |
| US-20020009467-A1 | Antigenic substance inductor, vaccine precursor, vaccine, antibody, neutralizing antibody, antitoxin, idiotype antibody and/or anti-idiotype antibody which is induced by its idiotype antibody | INHA, C3AR1, ICOS | ALDH1A1 890/4885FKBP5 4500/4885 |
| US-20080200558-A1 | Inhibitory or blocking agents of molecular generating and/or/ inducing functions | CD47, MCL1, BAK1 | ALDH1A1 1294/4885FKBP5 2051/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.